CRL — Charles River Laboratories

Charles River Laboratories (CRL) is a diagnostics & research company listed on NYSE. It is led by James C. Foster J.D., based in 251 Ballardvale Street, Wilmington, MA, United States, 01887, with about 18,700 employees. Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Latest reported CRL revenue for 2025-09-27 was $1.00B. Net income was $55.6M. Revenue was down 2.6% from 2025-06-28 to 2025-09-27. CRL currently screens at market cap $7.78B.

Use this CRL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRL SEC filings page. Lician reads the product cache first so this HTML stays unique to Charles River Laboratories even when a live quote feed is slow.